Stay updated on ASP1517 Intermittent Dosing in CKD Anemia Clinical Trial
Sign up to get notified when there's something new on the ASP1517 Intermittent Dosing in CKD Anemia Clinical Trial page.

Latest updates to the ASP1517 Intermittent Dosing in CKD Anemia Clinical Trial page
- Check7 days agoNo Change Detected
- Check13 days agoChange DetectedA new site revision label 'Revision: v3.4.2' was added, and the prior 'Revision: v3.4.1' notice plus a government funding notice were removed, indicating a minor site maintenance update – To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check20 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 and a government funding notice was added.SummaryDifference0.3%

- Check28 days agoChange DetectedAdditions include a 'Show glossary' option and a QC-related label 'Last Update Submitted that Met QC Criteria', and revision references were updated to v3.4.0 from v3.3.4. These are minor UI/metadata changes and do not affect core study content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check35 days agoChange DetectedCore elements such as sponsor and investigator information, IPD sharing policy details, and links to results and study documents have been removed.SummaryDifference17%

- Check42 days agoChange DetectedThe page now displays an added revision label 'Revision: v3.3.4', and the previous 'v3.3.3' label appears to be removed.SummaryDifference0.0%

- Check63 days agoChange DetectedThe Locations sections were updated to include multiple site locations (Aichi-ken, Chiba, Ehime, Fukuoka, Gifu, Gunma, Hiroshima, Hokkaido, Hyōgo, Ibaraki, Ishikawa-ken, Iwate, Kanagawa, Miyagi, Nagano, Osaka, Saitama, Tokyo) and a new Revision: v3.3.3, with some previous location entries removed.SummaryDifference1%

Stay in the know with updates to ASP1517 Intermittent Dosing in CKD Anemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASP1517 Intermittent Dosing in CKD Anemia Clinical Trial page.